https://www.live-feeds.com/feed/moderna-stock-jumps-its-mrna-cancer-vaccine-is-getting-ready-for-its-next-big-testContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/moderna-stock-jumps-its-mrna-cancer-vaccine-is-getting-ready-for-its-next-big-testhttps://www.live-feeds.com/feed/moderna-stock-jumps-its-mrna-cancer-vaccine-is-getting-ready-for-its-next-big-test#u81739Wed, 23 Sep 2026 20:16:23 +0000Moderna shares rose between 10% and 12% to reach a new high as the company prepares to present late-breaking data from a key melanoma trial at the ESMO Congress 2026. The surge comes as investors anticipate pipeline updates this week regarding the company's mRNA cancer vaccine. Market activity reflects growing interest in the efficacy of the vaccine's next testing phase and the results of the melanoma study.Why it mattersModerna is expanding its mRNA platform beyond COVID-19 into oncology. The ESMO Congress is a major venue for oncology research where clinical trial results can signi